NCT05106608 Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study Status RECRUITING Phase NA
NCT05083416 Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome Status COMPLETED Phase NA
NCT05081531 AI for Head Neck Cancer Treated With Adaptive RadioTherapy (RadiomicART) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05078047 Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO Status RECRUITING Phase PHASE3
NCT05076760 MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05061940 This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. Status TERMINATED Phase N/A
NCT05061537 Study of PF-07263689 in Participants With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05060432 Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05059340 Study to Explore Post Surgical Outcomes Using Point-of-Gaze, Electromyography and Elastography of the SCM Status COMPLETED Phase N/A
NCT05053230 A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer Status RECRUITING Phase NA
NCT05046028 Individualization of Nutritive Sensory Support Of Radiation Therapy Status COMPLETED Phase PHASE4
NCT05040425 Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis Status UNKNOWN Phase PHASE2
NCT05036902 The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer Status COMPLETED Phase N/A
NCT05028452 Feasibility of Internet Based Support (Carer eSupport) for Informal Caregivers of Patients With Head and Neck Cancer Status COMPLETED Phase NA
NCT05025813 Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma Status RECRUITING Phase PHASE2